Author:
Nogawa Toshihiko,Takahashi Shunji,Sekiyama Yasuyo,Takagi Hiroshi,Uramoto Masakazu,Koshino Hiroyuki,Kawatani Makoto,Shimizu Takeshi,Osada Hiroyuki
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference18 articles.
1. Osada, H., Koshino, H., Isono, K., Takahashi, H. & Kawanishi, G. Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor. J. Antibiot. 44, 259–261 (1991).
2. Takahashi, H. et al. Reveromycins, new inhibitors of eukaryotic cell growth. II. Biological activities. J. Antibiot. 45, 1414–1419 (1992).
3. Cui, Z., Hirata, D., Tsuchiya, E., Osada, H. & Miyakawa, T. The multidrug resistance-associated protein (MRP) subfamily (Yrs/Yor1) of Saccharomyces cerevisiae is important for the tolerance to a broad range of organic anions. J. Biol. Chem. 271, 14712–14716 (1996).
4. Takahashi, H. et al. Inhibitory action of reveromycin A on TGF-α-dependent growth of ovarian carcinoma BG-1 in vitro and in vivo. Oncol. Res. 9, 7–11 (1997).
5. Miyamoto, Y. et al. Identification of Saccharomyces cerevisiae isoleucyl-tRNA synthetase as a target of the G1-specific inhibitor Reveromycin A. J. Biol. Chem. 277, 28810–28814 (2002).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献